Giovanni Larciprete, Carlotta Montagnoli, Mariagrazia Frigo, Valentina Panetta, Cristina Todde, Benedetta Zuppani, Chiara Centonze, Alessandro Bompiani, Ioannis Malandrenis, Alio Cirese, Herbert Valensise
{"title":"Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage.","authors":"Giovanni Larciprete, Carlotta Montagnoli, Mariagrazia Frigo, Valentina Panetta, Cristina Todde, Benedetta Zuppani, Chiara Centonze, Alessandro Bompiani, Ioannis Malandrenis, Alio Cirese, Herbert Valensise","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>the aims of the present study were to compare the haemodynamic effects of oxytocin and carbetocin and to assess the efficacy of these two drugs in terms of blood loss and the additional uterotonic needed in caesarean section at high risk of primary post-partum haemorrhage.</p><p><strong>Methods: </strong>women in the carbetocin group (group A) received a bolus of 100 μg IV; women in the control group (group B) received 20 IU of oxytocin in 1000 ml of 0,9% Na-Cl solution IV (150 mL/hour). The main parameter evaluated was the haemodynamic effects of drugs and the need for additional uterotonic agents. In addition we compared the drop in haemoglobin level, the uterine tone, the uterine fundal state and the diuresis.</p><p><strong>Results: </strong>regarding the haemodynamic effects, both drugs have a hypotensive effect, but we found a greater reduction in blood pressure within the oxytocin group. Significantly more women needed additional uterotonic agents in the oxytocin group (23,5% vs 0%, p<0.01), though there was no significant difference in estimated blood loss and in the drop haemoglobin level (p>0.05). There was a significant difference in the diuresis, higher in carbetocin group (1300 ml ± 450 ml vs 1100 ml ± 250 ml, p=0.01).</p><p><strong>Conclusions: </strong>a single injection of carbetocin appears to be more effective than a continuous infusion of oxytocin to prevent the PPH, with a similar haemodynamic profile and minor antidiuretic effect.</p>","PeriodicalId":89592,"journal":{"name":"Journal of prenatal medicine","volume":"7 1","pages":"12-8"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671813/pdf/12-18.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of prenatal medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: the aims of the present study were to compare the haemodynamic effects of oxytocin and carbetocin and to assess the efficacy of these two drugs in terms of blood loss and the additional uterotonic needed in caesarean section at high risk of primary post-partum haemorrhage.
Methods: women in the carbetocin group (group A) received a bolus of 100 μg IV; women in the control group (group B) received 20 IU of oxytocin in 1000 ml of 0,9% Na-Cl solution IV (150 mL/hour). The main parameter evaluated was the haemodynamic effects of drugs and the need for additional uterotonic agents. In addition we compared the drop in haemoglobin level, the uterine tone, the uterine fundal state and the diuresis.
Results: regarding the haemodynamic effects, both drugs have a hypotensive effect, but we found a greater reduction in blood pressure within the oxytocin group. Significantly more women needed additional uterotonic agents in the oxytocin group (23,5% vs 0%, p<0.01), though there was no significant difference in estimated blood loss and in the drop haemoglobin level (p>0.05). There was a significant difference in the diuresis, higher in carbetocin group (1300 ml ± 450 ml vs 1100 ml ± 250 ml, p=0.01).
Conclusions: a single injection of carbetocin appears to be more effective than a continuous infusion of oxytocin to prevent the PPH, with a similar haemodynamic profile and minor antidiuretic effect.
目的:本研究的目的是比较催产素和卡贝托星的血液动力学效果,并评估这两种药物在原发性产后出血高危剖腹产中的失血和所需的额外子宫补剂方面的疗效。方法:卡贝托星组(A组)女性静脉滴注100μg;对照组(B组)的妇女在1000ml的0.9%氯化钠溶液IV(150mL/小时)中接受20IU的催产素。评估的主要参数是药物的血液动力学效果和是否需要额外的子宫收缩剂。此外,我们还比较了血红蛋白水平的下降、子宫张力、子宫底状态和利尿情况。结果:关于血液动力学效应,两种药物都有降压作用,但我们发现催产素组的血压下降幅度更大。催产素组需要额外的子宫收缩剂的女性明显增多(23.5%vs 0%,p0.05)。利尿方面有显著差异,卡贝托星组更高(1300 ml±450 ml vs 1100 ml±250 ml,p=0.01)。结论:单次注射卡贝托素似乎比连续输注催产素更有效地预防PPH,具有相似的血液动力学特征和轻微的抗利尿作用。